Taming the lion: The challenge of immunity in regenerative medicine

Regenerative Medicine

Volumn 10, Issue 3, 2015, Pages 227-229

  Fairchild, Paul J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

dendritic cells; graft versus host disease; hematopoietic stem cell transplantation; immune suppression; immunogenicity; mesenchymal stem cells; pluripotent stem cells; thymic involution

Indexed keywords

ADULT STEM CELL; DENDRITIC CELL; EDITORIAL; EMBRYONIC STEM CELL; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNITY; IMMUNOGENICITY; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; MESENCHYMAL STEM CELL; NONHUMAN; PERSONALIZED MEDICINE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REGENERATIVE MEDICINE; STEM CELL TRANSPLANTATION; T CELL DEPLETION; ART;

HUMANS; IMMUNITY; PORTRAITS AS TOPIC; REGENERATIVE MEDICINE;

EID: 84930006643     PISSN: 17460751     EISSN: 1746076X     Source Type: Journal    
DOI: 10.2217/rme.15.15     Document Type: Editorial

References (12)

1. Dazzi F. The UKRMP Immunomodulation Hub. Regen. Med. 10(3), 255-257 (2015).
2. Asante C, Ali R, Dazzi F et al. Organizational profile: UKRMP Immunomodulation Hub. Regen. Med. 10(3), 259-263 (2015).
3. Haworth R, Sharpe M. The issue of immunology in stem cell therapies: a pharmaceutical perspective. Regen. Med. 10(3), 231-234 (2015).
4. Roberton VH, Rosser AE, Kelly CM. Neonatal desensitisation for the study of regenerative medicine. Regen. Med. 10(3), 265-274 (2015).
5. Wilmut I, Leslie S, Nicholas G et al. Development of a global network of induced pluripotent stem cell haplobanks. Regen. Med. 10(3), 235-238 (2015).
6. Bolton EM, Bradley JA. Avoiding immunological rejection in regenerative medicine. Regen. Med. 10(3), 287-304 (2015).
7. Vertes AA. The potential of cytotherapeutics in hematologic reconstitution and in the treatment and prophylaxis of graft-versus-host disease. Chapter I: Current practice and remaining unmet medical needs. Regen. Med. 10(3), 331-343 (2015).
8. Vertes AA. The potential of cytotherapeutics in hematologic reconstitution and in the treatment and prophylaxis of graftversus-host disease. Chapter II: Emerging transformational cytotherapies. Regen. Med. 10(3), 345-373 (2015).
9. Consentius C, Reinke P, Volk HD. Immunogenicity of allogeneic mesenchymal stromal cells-what has been seen in vitro and in vivo? Regen. Med. 10(3), 305-315 (2015).
10. Or-Geva N, Reisner Y. Exercising 'veto' power to make haploidentical hematopoietic stem cell transplantation a safe modality for induction of immune tolerance. Regen. Med. 10(3), 239-242 (2015).
11. Fairchild PJ, Leishman A, Sachamitr P, Telfer C, Hackett S, Davies TJ. Dendritic cells and pluripotency: unlikely allies in the pursuit of immunotherapy. Regen. Med. 10(3), 275-286 (2015).
12. Bredenkamp N, Jin X, Liu D, O'Neill KE, Manley N, Blackburn CB. Construction of a functional thymic microenvironment from pluripotent stem cells for the induction of central tolerance. Regen. Med. 10(3), 317-329 (2015).